Campylobacter jejuni: Difference between revisions
From IDWiki
Campylobacter jejuni
m (typo) |
No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Background== |
|||
⚫ | |||
===Microbiology=== |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
===Epidemiology=== |
|||
⚫ | |||
==Clinical Manifestations== |
|||
⚫ | |||
==Diagnosis== |
|||
*Stool culture or PCR |
|||
==Management== |
|||
*Supportive care for the diarrhea |
|||
*Antibiotic choice depends on where the infection was acquired |
|||
**[[Is treated by::Ciprofloxacin]] 500 mg PO bid for 3 days is useful where there are relatively low rates of resistance (North American and Europe) |
|||
***Or other fluoroquinolone for 3 days |
|||
**[[Is treated by::Azithromycin]] 500 mg PO daily for 3 days is useful where there are higher rates of resistance (especially South and Southeast Asia) |
|||
**An alternative is [[Is treated by::rifaximin]] 200 mg PO tid for 3 days, but should be avoided in patients who have [[dysentery]] or [[fever]] |
|||
*Resistant to most first- through third-generation [[cephalosporins]], but still susceptible to [[carbapenems]] |
|||
==Prognosis== |
|||
*Usually a self-limited illness whose duration is shortened by antibiotics |
|||
*Can subsequently develop [[Causes::post-infectious irritable bowel syndrome]] |
|||
*Most common cause of [[Causes::Guillain-Barré syndrome]] |
|||
{{DISPLAYTITLE:''Campylobacter jejuni''}} |
{{DISPLAYTITLE:''Campylobacter jejuni''}} |
||
[[Category: |
[[Category:Gram-negative bacilli]] |
Latest revision as of 15:52, 10 January 2021
Background
Microbiology
- Curved Gram-negative bacillus
- Grows best at 42ºC (body temperature of birds)
- Exhibits darting motility
Epidemiology
- Major host is birds, including poultry
Clinical Manifestations
- Causes infectious diarrhea, including dysentery
Diagnosis
- Stool culture or PCR
Management
- Supportive care for the diarrhea
- Antibiotic choice depends on where the infection was acquired
- Ciprofloxacin 500 mg PO bid for 3 days is useful where there are relatively low rates of resistance (North American and Europe)
- Or other fluoroquinolone for 3 days
- Azithromycin 500 mg PO daily for 3 days is useful where there are higher rates of resistance (especially South and Southeast Asia)
- An alternative is rifaximin 200 mg PO tid for 3 days, but should be avoided in patients who have dysentery or fever
- Ciprofloxacin 500 mg PO bid for 3 days is useful where there are relatively low rates of resistance (North American and Europe)
- Resistant to most first- through third-generation cephalosporins, but still susceptible to carbapenems
Prognosis
- Usually a self-limited illness whose duration is shortened by antibiotics
- Can subsequently develop post-infectious irritable bowel syndrome
- Most common cause of Guillain-Barré syndrome